Papillomavirus research update: Highlights of the Barcelona HPV 2000 international papillomavirus conference

Journal of Clinical Pathology

Volumn 54, Issue 3, 2001, Pages 163-175

  Bosch, F X ^a   Smith, P G ^f   Munoz N ^g   Zur Hausen, H ^h   Rohan, T ^b   Schneider, A ^c   Frazer, I ^d   Pfister, H ^e   Castellsague, X ^a   De Sanjose, S ^a   Moreno, V ^a   Puig Tintore, L M ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e UNIVERSITY OF COLOGNE   (Germany)

^f LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^g INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^h GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Biology; Epidemiology; Immunology; Papillomavirus; Screening

Indexed keywords

3 INDOLEMETHANOL; ENDOTHELIN RECEPTOR ANTAGONIST; IMIQUIMOD; INTERFERON; THYMIDINE KINASE; VIRUS PROTEIN; VISCUM ALBUM EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; CLINICAL TRIAL; COLPOSCOPY; COMORBIDITY; CONFERENCE PAPER; CONTINUING EDUCATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; GENE THERAPY; HUMAN; IMMUNE DEFICIENCY; MASS SCREENING; MEDICAL EDUCATION; MEDICAL RESEARCH; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; VIRUS CELL INTERACTION; VIRUS DETECTION; VIRUS INFECTION; VIRUS REPLICATION; VIRUS TRANSCRIPTION; VISCUM ALBUM; WART VIRUS;

FEMALE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; SPAIN; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VIRAL VACCINES;

EID: 0035092084     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.54.3.163     Document Type: Conference Paper

References (19)

1. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: Baseline data from a randomized trial
2. A systematic review of the role of human papillomavirus testing within a cervial screening program
3. Human papillomavirus infection
4. Human papillomavirus and the development of non-melanoma skin cancer
5. The natural history of dysplasia of the uterine cervix
6. Human papillomavirus DNA testing for cervical cancer screening in low-resource settings
7. Identifying women with cervical neoplasia. Using human papillomavirus DNA testing for equivocal Papanicolaou results
8. Cervical cytology after 2000: Where to go?
9. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: A prospective study
10. Evidence for a nonallelic heterogeneity of epidermodysplasia verruciformis with two susceptibility loci mapped to chromosome regions 2p21-p24 and 17q25
11. PCR based high risk HPV testing is superior to neural network based screening for predicting incident CIN III in women with normal cytology and borderline changes
12. Variation in the nucleotide sequence of cottontail rabbit papillomavirus a and b subtypes affects wart regression and malignant transformation and level of viral replication in domestic rabbits
13. HPV DNA testing in cervical cancer screening. Results from women in a high-risk province of Costa Rica
14. The E8E2C protein, a negative regulator of viral transcription and replication, is required for extrachromosomal maintenance of human papillomavirus type 31 in keratinocytes
15. Comparison of human papillomavirus detection and typing by cycle sequencing, line blotting, and hybrid capture
16. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
17. Papillomavirus E2 induces senescence in HPV-positive cells via pRB- and p21(CIP)-dependent pathways
18. Papillomaviruses causing cancer: Evasion from host-cell control in early events in carcinogenesis